Relationship of insulin resistance and overweight with cortisol and dehydroepiandrosterone-sulfate levels

Archives of Medical Research

Volumn 33, Issue 6, 2002, Pages 524-530

  Mino, Dolores ^a,e   Amato, Dante ^a   Cuevas, María Luisa ^b   Fonseca, María Eugenia ^c   Búrbano, Gabriel ^d   Wacher, Niels ^c   Lifshitz, Alberto ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b HOSPITAL DE PEDIATRÍA   (Mexico)

^c HOSPITAL DE ESPECIALIDADES   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^e NONE   (Mexico)

Author keywords

Hormones; Insulin resistance; Overweight

Indexed keywords

CHOLESTEROL; ESTROGEN RECEPTOR; GLUCOSE; HYDROCORTISONE; INSULIN; PRASTERONE SULFATE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; HUMAN; HUMAN EXPERIMENT; INSULIN RESISTANCE; MEXICO; NORMAL HUMAN; OBESITY; PRINCIPAL COMPONENT ANALYSIS; PROFESSIONAL PRACTICE; PROTEIN BINDING; SOCIOECONOMICS; URBAN POPULATION;

ADULT; AGE FACTORS; BLOOD GLUCOSE; BODY MASS INDEX; BODY WEIGHT; CHOLESTEROL; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; HUMANS; HYDROCORTISONE; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; REGRESSION ANALYSIS; SEX FACTORS; TIME FACTORS; TRIGLYCERIDES;

EID: 0036867189     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0188-4409(02)00400-9     Document Type: Article

References (21)

1. Björntorp P. Endocrine abnormalities of obesity. Metabolism. 44(Suppl 3):1995;21s-23s.
2. Björntorp P. Insulin resistance. the consequence of a neuroendocrine disturbance? Int J Obes. 19(Suppl 1):1995;6s-10s.
3. Keltikangas-Järvinen L., Räikkönen K., Hautanen A., Adlercreutz H. Vital exhaustion, anger expression, and pituitary and adrenocortical hormones. Implications for the insulin resistance syndrome. Arterioscler Thromb Vasc Biol. 16:1996;275-280.
4. Walker R.B., Soderberg S., Lindahl B., Olsson T. Independent effects of obesity and cortisol in predicting cardiovascular risk factors in men and women. J Intern Med. 247:2000;198-204.
5. Brindley D.N. Role of glucocorticoids and fatty acids in the impairment of lipid metabolism observed in the metabolic syndrome. Int J Obes. 19(Suppl 1):1995;69s-75s.
6. Stewart P.M., Boulton A., Kumar S., Clark P.M., Shackleton C.H. Cortisol metabolism in human obesity. impaired cortisone > cortisol conversion in subjects with central adiposity J Clin Endocrinol Metab. 84:1999;1022-1027.
7. Stolk R.P., Lamberts S.W.J., De Jong F.H., Pols H.A.P., Grobbee D.E. Gender differences in the associations between cortisol and insulin in healthy subjects. J Endocrinol. 149:1996;313-318.
8. Ebeling P., Koivisto V.A. Physiological importance of dehydroepiandrosterone. Lancet. 343:1994;1479-1481.
9. Haffner S.M., Karhapää P., Mykkänen L., Laakso M. Insulin resistance, body fat distribution, and sex hormones in men. Diabetes. 43:1994;212-219.
10. Ebeling P., Stenman U.H., Sepälä M., Koivisto V.A. Acute hyperinsulinemia, androgen homeostasis and insulin sensitivity in healthy men. J Endocrinol. 146:1995;63-69.
11. Mino D., Wacher N., Amato D., Búrbano G., Fonseca M.E., Revilla C., Gordon F., Lifshitz A. Insulin resistance in offspring of hypertensive subjects. J Hypertens. 14:1996;1189-1193.
12. Yalow R., Berson S. Immunoassay of endogenous plasma insulin in man. J Clin Invest. 39:1960;1157-1175.
13. Haffner S., González C., Miettinen H., Kennedy E., Stern M. A prospective analysis of the HOMA model. Diabetes Care. 19:1996;1138-1141.
14. Armitage P, Berry G. Mediciones múltiples: métodos multivariantes. In: Estadística para investigación biomédica. Barcelona, Spain: Doyma;1992. p. 381.
15. Catell R. Factor analysis. an introduction to essentials Biometrics. 21:1965;190-215.
16. Johannes C.B., Stellato R.K., Feldman H.A., Longcope C., McKinlay J.B. Relation of dehydroepiandrosterone and dehydroepiandrosterone sulfate with cardiovascular disease risk factors in women. longitudinal results from the Massachusetts Women's Health Study J Clin Epidemiol. 52:1999;95-103.
17. Mazza E., Maccario M., Ramunni J., Gauna C., Bertagna A., Barberis A.M., Patroncini S., Messina M., Ghigo E. Dehydroepiandrosterone sulfate levels in women. Relationships with age, body mass index and insulin levels. J Endocrinol Invest. 22:1999;681-687.
18. Feldman H.A., Johannes C.B., Araujo A.B., Mohr B.A., Longcope C., McKinlay J.B. Low dehydroepiandrosterone and ischemic heart disease in middle-aged men. prospective results from the Massachusetts Male Aging Study Am J Epidemiol. 153:2001;79-89.
19. Björntorp P., Rosmond R. Obesity and cortisol. Nutrition. 16:2000;924-936.
20. Hautanen A., Adlercreutz H. Altered adrenocorticotropin and cortisol secretion in abdominal obesity. implications for the insulin resistance syndrome J Intern Med. 234:1993;461-469.
21. Hautanen A., Räikkönen K., Adlercreutz H. Associations between pituitary-adrenocortical function and abdominal obesity, hyperinsulinaemia and dyslipidaemia in normotensive males. J Intern Med. 241:1997;451-461.